Search Results

There are 15800 results for: content related to: Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma

  1. Bicalutamide-Associated Fulminant Hepatotoxicity

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 8, August 2008, Pages: 1071–1075, Dr. Cindy L. O'Bryant, Dr. Thomas W. Flaig and Dr. Kenneth J. Utz

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.8.1071

  2. You have free access to this content
    Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: Informed scheduling of the bioreductive drug AQ4N improves treatment response

    International Journal of Cancer

    Volume 132, Issue 6, 15 March 2013, Pages: 1323–1332, Louise Ming, Niall M. Byrne, Sarah Nicole Camac, Christopher A. Mitchell, Claire Ward, David J. Waugh, Stephanie R. McKeown and Jenny Worthington

    Version of Record online : 23 NOV 2012, DOI: 10.1002/ijc.27796

  3. Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects

    The Journal of Sexual Medicine

    Volume 9, Issue 3, March 2012, Pages: 887–902, Giovanni Corona, Mauro Gacci, Elisabetta Baldi, Rosa Mancina, Gianni Forti and Mario Maggi

    Version of Record online : 16 JAN 2012, DOI: 10.1111/j.1743-6109.2011.02590.x

  4. You have free access to this content
    Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer

    BJU International

    Volume 105, Issue 8, April 2010, Pages: 1082–1088, Vivek K. Wadhwa, Robin Weston and Nigel J. Parr

    Version of Record online : 13 NOV 2009, DOI: 10.1111/j.1464-410X.2009.08956.x

  5. You have free access to this content
    Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer

    BJU International

    Volume 107, Issue 12, June 2011, Pages: 1923–1929, Vivek K. Wadhwa, Robin Weston and Nigel J. Parr

    Version of Record online : 15 OCT 2010, DOI: 10.1111/j.1464-410X.2010.09726.x

  6. You have free access to this content
    Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1721–1728, Karol Axcrona, Sirpa Aaltomaa, Carlos Martins da Silva, Haluk Özen, Jan-Erik Damber, László B. Tankó, Enrico Colli and Peter Klarskov

    Version of Record online : 13 APR 2012, DOI: 10.1111/j.1464-410X.2012.11107.x

  7. You have free access to this content
    Androgen deprivation therapy: past, present and future

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 1–12, F. Schröder, E.D. Crawford, K. Axcrona, H. Payne and T.E. Keane

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11215.x

  8. You have free access to this content
    Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years

    BJU International

    Volume 105, Issue 8, April 2010, Pages: 1074–1081, Peter Iversen, David G. McLeod, William A. See, Thomas Morris, Jon Armstrong, Manfred P. Wirth and on behalf of the Casodex Early Prostate Cancer Trialists’ Group

    Version of Record online : 25 MAR 2010, DOI: 10.1111/j.1464-410X.2010.09319.x

  9. You have free access to this content
    Hormonal therapy for prostate cancer: Current topics and future perspectives

    International Journal of Urology

    Volume 17, Issue 4, April 2010, Pages: 302–313, Hiroyoshi Suzuki, Shiro Hinotsu, Hideyuki Akaza, Yasuhisa Fujii, Satoru Kawakami, Kazunori Kihara, Koichiro Akakura, Motofumi Suzuki, Tadaichi Kitamura, Yukio Homma and Atsushi Mizokami

    Version of Record online : 22 MAR 2010, DOI: 10.1111/j.1442-2042.2010.02460.x

  10. You have free access to this content
    Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values

    BJU International

    Volume 104, Issue 6, September 2009, Pages: 800–805, Vivek K. Wadhwa, Robin Weston, Rahul Mistry and Nigel J. Parr

    Version of Record online : 11 MAR 2009, DOI: 10.1111/j.1464-410X.2009.08483.x

  11. You have free access to this content
    Concept and viability of androgen annihilation for advanced prostate cancer

    Cancer

    Volume 120, Issue 17, September 1, 2014, Pages: 2628–2637, James L. Mohler

    Version of Record online : 25 APR 2014, DOI: 10.1002/cncr.28675

  12. Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 875–885, Christian Thomas, Latif A. Wafa, Francois Lamoureux, Helen Cheng, Ladan Fazli, Martin E. Gleave and Paul S. Rennie

    Version of Record online : 5 OCT 2011, DOI: 10.1002/pros.21490

  13. Endocrine Therapy for Prostate Cancer: The Latest

    Challenges in Prostate Cancer, Second Edition

    A. Goyal, W. Bowsher, Pages: 137–152, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470755006.ch12

  14. You have free access to this content
    Androgen deprivation therapy for prostate cancer and its complications

    Trends in Urology, Gynaecology & Sexual Health

    Volume 15, Issue 3, May/June 2010, Pages: 32–37, Mr Alvan J. Pope and Mr Paul D. Abel

    Version of Record online : 8 JUN 2010, DOI: 10.1002/tre.150

  15. Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor–positive salivary gland cancers

    Head & Neck

    Volume 38, Issue 5, May 2016, Pages: 724–731, Laura D. Locati, Federica Perrone, Barbara Cortelazzi, Salvatore Lo Vullo, Paolo Bossi, Gianpaolo Dagrada, Pasquale Quattrone, Cristiana Bergamini, Paolo Potepan, Enrico Civelli, Carlo Fallai, Silvana Pilotti and Lisa Licitra

    Version of Record online : 25 JUN 2015, DOI: 10.1002/hed.23940

  16. You have free access to this content
    Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer

    Intervention Review

    The Cochrane Library

    Frank Kunath, Henrik R Grobe, Gerta Rücker, Edith Motschall, Gerd Antes, Philipp Dahm, Bernd Wullich and Joerg J Meerpohl

    Published Online : 30 JUN 2014, DOI: 10.1002/14651858.CD009266.pub2

  17. Androgen deprivation and androgen receptor competition by bicalutamide induce autophagy of hormone-resistant prostate cancer cells and confer resistance to apoptosis

    The Prostate

    Volume 73, Issue 10, July 2013, Pages: 1090–1102, Benoît Boutin, Nicolas Tajeddine, Patrick Vandersmissen, Nadège Zanou, Monique Van Schoor, Ludivine Mondin, Pierre J. Courtoy, Bertrand Tombal and Philippe Gailly

    Version of Record online : 26 MAR 2013, DOI: 10.1002/pros.22658

  18. Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo

    The Prostate

    Volume 69, Issue 7, 15 May 2009, Pages: 744–754, Matteo Landriscina, Cinzia Bagalà, Annamaria Piscazzi, Giovanni Schinzari, Michela Quirino, Annarita Fabiano, Sara Bianchetti, Alessandra Cassano, Gigliola Sica and Carlo Barone

    Version of Record online : 16 JAN 2009, DOI: 10.1002/pros.20923

  19. You have free access to this content
    The patient's choice of androgen-deprivation therapy in locally advanced prostate cancer: bicalutamide, a gonadotrophin-releasing hormone analogue or orchidectomy

    BJU International

    Volume 96, Issue 7, November 2005, Pages: 1014–1018, Claes R. Nyman, Jesper T. Andersen, Per Lodding, Thorsten Sandin and Eberhard Varenhorst

    Version of Record online : 13 OCT 2005, DOI: 10.1111/j.1464-410X.2005.05802.x

  20. You have free access to this content
    Evidence-based medicine: comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1200–1208, Santiago Vilar González and Xavier Maldonado Pijuan

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09827.x